<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Aggressive lipid lowering improves the outcome after coronary artery bypass graft</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Aggressive lipid lowering improves the outcome after coronary artery bypass graft</h1>
<div class="graphic"><div class="figure"><div class="ttl">Aggressive lipid lowering improves the outcome after coronary artery bypass graft</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">In the Post Coronary Artery Bypass Graft trial, which enrolled 1351 patients, aggressive lipid-lowering therapy with lovastatin and, if needed, cholestyramine insignificantly reduced the composite clinical end point of death, myocardial infarction, need for revascularization procedures, or stroke by 18% at the end of the trial. However, at the end of the 7.5-year extended follow-up period, there was a significant 24% reduction in the composite clinical endpoint (p = 0.001).</div><div class="graphic_reference">Data from: Knatterud GL, Rosenberg Y, Campeau L, et al. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation 2000; 102:157.</div><div id="graphicVersion">Graphic 74401 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
